|
|
||||||||
American Journal of Clinical Nutrition, Vol 33, 1509-1516, Copyright © 1980 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
AC Alfrey, A Hegg and P Craswell
Aluminum levels were measured in a variety of tissues obtained from 36 control subjects, 30 nondialyzed uremic patients, 57 dialyzed uremic patients dying of a variety of different causes, and 38 dialyzed uremic patients dying of dialysis encephalopathy. The low aluminum levels consistently found in the control tissues support the fact that in health aluminum is largely excluded from the body. However, this ability to prevent aluminum accumulation is overcome with renal failure. Bone and liver aluminum levels were found to be significantly increased in 82% and 56% respectively in nondialyzed uremic patients and in 100% of the tissues examined from dialyzed uremic patients. In patients dying of dialysis encephalopathy, tissue aluminum levels were not only the highest but also affected in a different manner than that found in other dialyzed patients. It is suggested that dialysis encephalopathy occurs as a result of such rapid aluminum loading during dialysis that bone's ability to sequester this element is overcome, and it is shunted to liver and brain with resulting toxicity.
This article has been cited by other articles:
![]() |
J. W. Nicholson and B. Czarnecka Review Paper: Role of Aluminum in Glass-ionomer Dental Cements and its Biological Effects J Biomater Appl, November 1, 2009; 24(4): 293 - 308. [Abstract] [PDF] |
||||
![]() |
S. Dey, V. Bakthavatchalu, M. T. Tseng, P. Wu, R. L. Florence, E. A. Grulke, R. A. Yokel, S. K. Dhar, H.-S. Yang, Y. Chen, et al. Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells Carcinogenesis, October 1, 2008; 29(10): 1920 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kutlubay, E. O. Oguz, C. Guven, B. Can, Z. Sinik, and O. L. Tuncay Histological and Ultrastructural Evidence for Protective Effects on Aluminium-Induced Kidney Damage by Intraperitoneal Administration of {alpha}-Tocopherol International Journal of Toxicology, March 1, 2007; 26(2): 95 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Yokel, S. S. Rhineheimer, P. Sharma, D. Elmore, and P. J. McNamara Entry, Half-Life, and Desferrioxamine-Accelerated Clearance of Brain Aluminum after a Single 26Al Exposure Toxicol. Sci., November 1, 2001; 64(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cooke and M.H. Gould The Health Effects of Aluminium -- A Review Perspectives in Public Health, October 1, 1991; 111(5): 163 - 168. [Abstract] |
||||
![]() |
J. D. Hanna, J. W. Foreman, and J. C.M. Chan Chronic Renal Insufficiency in Infants and Children Clinical Pediatrics, June 1, 1991; 30(6): 365 - 384. [PDF] |
||||
![]() |
M. E. A. Bozynski, A. B. Sedman, R. A. Naglie, and E. J. Wright Serial Plasma and Urinary Aluminum Levels and Tissue Loading in Preterm Twins JPEN J Parenter Enteral Nutr, July 1, 1989; 13(4): 428 - 431. [Abstract] [PDF] |
||||
![]() |
R. A. Yokel Aluminum and Alzheimer's Disease: Should We Worry? Journal of Pharmacy Practice, October 1, 1988; 1(2): 118 - 127. [PDF] |
||||
![]() |
D. S. MILLINER, H. G. NEBEKER, S. M. OTT, D. L. ANDRESS, D. J. SHERRARD, A. C. ALFREY, E. A. SLATOPOLSKY, and J. W. COBURN Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related Osteodystrophy Ann Intern Med, December 1, 1984; 101(6): 775 - 780. [Abstract] [PDF] |
||||
![]() |
H. L. Skalsky and R. A. Carchman Aluminum Homeostasis in Man International Journal of Toxicology, November 1, 1983; 2(6): 405 - 423. [Abstract] [PDF] |
||||
![]() |
H. Spencer and L. Kramer Antacid-Induced Calcium Loss Arch Intern Med, April 1, 1983; 143(4): 657 - 659. [Abstract] [PDF] |
||||
![]() |
A. B. HODSMAN, D. J. SHERRARD, E. G. C. WONG, A. S. BRICKMAN, D. B. N. LEE, A. C. ALFREY, F. R. SINGER, A. W. NORMAN, and J. W. COBURN Vitamin-D-Resistant Osteomalacia in Hemodialysis Patients Lacking Secondary Hyperparathyroidism Ann Intern Med, May 1, 1981; 94(5): 629 - 637. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |